Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
39965834 | 3996583 | 4 | F | 20030627 | 20160826 | 20030910 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-12370722 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 1.90000 | KG | 20160826 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
39965834 | 3996583 | 1 | PS | VIDEX | DIDANOSINE | 1 | Transplacental | UNK | U | 20156 | |||||||||
39965834 | 3996583 | 2 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
39965834 | 3996583 | 3 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
39965834 | 3996583 | 4 | SS | LOXEN | NICARDIPINE HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 | |||||||||
39965834 | 3996583 | 5 | SS | ZOVIRAX | ACYCLOVIR | 1 | Transplacental | UNK | U | 0 | |||||||||
39965834 | 3996583 | 6 | SS | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 | |||||||||
39965834 | 3996583 | 7 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
39965834 | 3996583 | 1 | Product used for unknown indication |
39965834 | 3996583 | 2 | Product used for unknown indication |
39965834 | 3996583 | 3 | Product used for unknown indication |
39965834 | 3996583 | 4 | Product used for unknown indication |
39965834 | 3996583 | 5 | Product used for unknown indication |
39965834 | 3996583 | 6 | Product used for unknown indication |
39965834 | 3996583 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
39965834 | 3996583 | LT |
39965834 | 3996583 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
39965834 | 3996583 | Blood creatine phosphokinase increased | |
39965834 | 3996583 | Blood disorder | |
39965834 | 3996583 | Blood lactate dehydrogenase increased | |
39965834 | 3996583 | Blood lactic acid increased | |
39965834 | 3996583 | Foetal distress syndrome | |
39965834 | 3996583 | Foetal exposure during pregnancy | |
39965834 | 3996583 | Foetal heart rate abnormal | |
39965834 | 3996583 | Haemoglobin decreased | |
39965834 | 3996583 | Lipase increased | |
39965834 | 3996583 | Necrotising colitis | |
39965834 | 3996583 | Premature baby | |
39965834 | 3996583 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
39965834 | 3996583 | 1 | 20021212 | 20030627 | 0 | |
39965834 | 3996583 | 2 | 20021212 | 20030627 | 0 | |
39965834 | 3996583 | 3 | 20021212 | 20030627 | 0 | |
39965834 | 3996583 | 4 | 20030528 | 0 | ||
39965834 | 3996583 | 5 | 20030528 | 0 | ||
39965834 | 3996583 | 6 | 20021216 | 0 | ||
39965834 | 3996583 | 7 | 20021216 | 0 |